Abstract
Analysis of cardiovascular development in zebrafish embryos has become a major driver of vascular research in recent years. Imaging-based analyses have allowed the discovery or verification of morphologically distinct processes and mechanisms of, e.g., endothelial cell migration, angiogenic sprouting, tip or stalk cell behavior, and vessel anastomosis. In this chapter, we describe the techniques and tools used for confocal imaging of zebrafish endothelial development in combination with general experimental approaches for molecular dissection of involved signaling pathways.
You have full access to this open access chapter, Download protocol PDF
Similar content being viewed by others
Key words
- Angiogenesis
- Confocal microscopy
- Development
- Endothelial cell migration
- In vivo time-lapse imaging
- Live imaging
- Vascular morphogenesis
- Zebrafish
1 Introduction
The essential function of regulating oxygen and nutrient supply demands that the cardiovascular system is one of the first vertebrate organs to form. Its implication in many human diseases is based on its additional role in immune cell and hormone trafficking as well as its heterogeneity, allowing for tissue-specific or regional specializations of different vascular beds that differ in shape and function.
The vascular system emerges from mesoderm-derived precursors in a process called vasculogenesis [1]. Hereafter, new blood vessels emanate from pre-existing vessels, which is referred to as angiogenesis [2]. The invasion of endothelial cells into avascular tissue is a tightly controlled process that includes highly conserved signaling mechanisms that transmit attracting or repelling cues to control blood vessel sprouting [3,4,5,6,7]. Detailed analysis of vascular morphogenesis in zebrafish (Danio rerio) embryos has been used in order to identify potential regulators of angiogenesis [6,7,8,9].
Development of the zebrafish cardiovascular system follows the same or highly homologous morphological and molecular events as in mammals [10,11,12]. The advantages of using zebrafish as a model system are based on its rapid development in translucent embryos and the high offspring count [13]. Moreover, owing to external fertilization, the zebrafish embryo is easily amenable to both developmental observation and experimental manipulation, including pharmacologic and genetic approaches. Genetic manipulation provides a broad variety of possibilities such as gene knockdown by using morpholino antisense oligonucleotides [14], genome editing through CRISPR-Cas9 for gene knockout or knock-in approaches [15,16,17,18], or DNA/RNA overexpression studies [19, 20]. Another advantage is the transparency of the small embryos allowing high-resolution imaging techniques to assess endothelial cell behavior at single-cell resolution in vivo over short as well as multiple-day time spans [21,22,23,24,25]. Additionally, the small size of the embryos enables fast passive oxygen and nutrient diffusion throughout their whole body. Hence, embryos can survive for several days without a functional vascular system [26].
In addition to these advantages for analysis during embryonic development, adult zebrafish have been used to study regenerative processes of heart tissue and fin vasculature [27,28,29].
The vascular anatomy of the developing zebrafish embryo and the underlying cellular processes have been described in detail over the last two decades [6,7,8,9, 24, 30].
In zebrafish, endothelial cells can be visualized by vascular-specific transgenes that result in cell-specific fluorophore expression [31, 32]. Additionally, other cells like perivascular cells or immune cells can be visualized in zebrafish embryos to study the interactions of endothelial cells with their environment [33, 34]. Table 1 lists different transgenic zebrafish lines that visualize endothelial cells and their subcellular compartments [11, 25, 31, 32, 35,36,37,38,39,40,41,42,43,44,45,46].
The major components of the first circulatory loop of zebrafish embryos encompass a beating heart, the dorsal aorta, and the cardinal veins [6]. Hereafter, other vascular beds in the trunk, the tail, and the brain develop to form a diversely branched vascular network with different vessel calibers and tissue-specific heterogeneity.
In this chapter, we will focus on the formation of three different vascular beds: the intersegmental vessels (ISVs), the intracerebral central arteries (CtAs), and the common cardinal veins (CCVs) (shown in Figs. 1 and 2). Figure 1 provides a developmental overview of the formation of the three heterogenous vessel types, while Fig. 2 displays examples of the visualization of different subcellular compartments in endothelial cells, as mentioned in Table 1.
Firstly, we will concentrate on the ISVs, which sprout from the dorsal aorta (DA) to migrate dorsally between the segments of the trunk and the tail (Fig. 1a). By connecting with other migrating ISV endothelial cells, they build up the dorsal longitudinal anastomotic vessel (DLAV). Through random reconnection of half of these ISVs with sprouts from the posterior cardinal vein (PCV), these endothelial cells form circulatory loops ensuring blood supply through the somites [24]. Initial angiogenic sprouting starts at around 19 h post fertilization (hpf) in the trunk region and continues in a rostral to caudal progression [6, 7]. After secondary venous sprouting, the final circulatory loop is fully established before 48 hpf [6, 7]. Due to their regular and stereotypic pattern and their superficial position, the ISVs have become the most used vascular bed for the observation of sprouting angiogenesis and vessel development in zebrafish. Naturally, various signaling processes are involved in the formation of the ISVs. The initial endothelial cell migration from the DA is, among others, mainly stimulated through vascular endothelial growth factor a (VEGFa) [6, 7, 24].
Secondly, the CtAs serve as an ideal example of tissue-specific heterogeneity, as these brain vessels form the blood-brain barrier, characterized by distinct junction properties (regulated through tight junction proteins) and distinct transport mechanisms [47]. The intracerebral CtAs (also known as hindbrain capillaries) invade the avascular brain parenchyma at around 32 hpf, originating from the primordial hindbrain channels (PHBC) (Fig. 1a). A single tip cell initially migrates dorsally before the vessel loops back and connects to the medial basilar artery (BA) [47,48,49,50]. Alternatively, CtA cells may also connect laterally to other CtAs [47]. At around 48 hpf, the CtAs are fully developed and carry blood [47,48,49,50]. Mechanistically, it has been shown that Wnt signaling in these endothelial cells is indispensable during CtA formation. Here, Wnt signaling reflects an important function in defining pre-tip cell specifications and later on also vascular patterning and vessel anastomosis [33, 47].
Lastly, we focus on the formation of the CCVs, which start their formation together with the more dorsally located cardinal veins with angioblast migration around 17 hpf. The bilateral CCVs collect blood from the cardinal veins and transport it back to the heart. However, unlike any other vessel of the embryo, the CCVs already transport blood from around 25 hpf onward, although they are still actively undergoing angiogenesis, more specifically cell migration. The formation of these vessels is finished, when CCV endothelial cells connect to the cardiac endothelial cells of the inflow tract and finally close around their lumen, which happens at around 50 hpf. During the formation of the CCV, endothelial cells migrate collectively as a sheet toward the ventral side of the yolk, before extending to the cranioventral side to connect to the heart (Fig. 1a) [25, 51]. This process is different to the other two presented models as there is no single tip cell leading sprouting involved. In this case, communication within the endothelial cell sheet is a major regulator of pattern formation [6, 24, 51]. However, similar to other vascular beds, this mode of endothelial cell migration is also controlled by various signals [25, 51].
Here, we describe the preparation of zebrafish embryos in order to image angiogenesis in the three abovementioned vascular beds. We provide detailed instructions on how to treat embryos for confocal microscopy including mounting techniques. Although several different methods can be used to study vascular morphogenesis in zebrafish, such as in situ hybridization techniques or antibody staining experiments, we will focus on fluorescent in vivo live-imaging approaches [52, 53]. Additionally, we provide three analysis examples, one for each introduced vessel type, on how to quantify endothelial cell behavior in zebrafish embryos.
However, in addition to the here described methods, other recently developed techniques to advance from tissue and cellular observations toward more detailed molecular observations are becoming available. While there are no easy-to-use protocols existing at present, the future will contain applications like the use of Förster resonance energy transfer (FRET) sensor probes [54,55,56]. Using vascular tension sensors, changes in inter- and intracellular tension have been measured at single-molecule resolution, for instance, by using a transgenic zebrafish line expressing a vascular endothelial (VE)-cadherin tension sensor to determine junctional tension between adjacent endothelial cells [57]. However, challenges include the need for biological single-fluorophore controls, a specialized microscopy setup (two-photon excitation), and the respective transgenic lines.
Nevertheless, many important observations were made in zebrafish using basic confocal microscopy in the last decades. As described in this chapter, multicellular structures and subcellular compartments can be visualized in zebrafish without the need for any super-resolution techniques. Thanks to live imaging approaches in zebrafish, processes such as vascular lumen formation could be analyzed in more detail than in mouse models leading to new discoveries in our biological understanding [6].
2 Materials
2.1 General Vascular Assessment
2.1.1 Preparing Embryos
-
1.
Fertilized zebrafish embryos.
-
2.
Incubator (such as Memmert IPP30).
-
3.
60× zebrafish E3 embryo medium: 0.3 M NaCl, 10 mM KCl, 20 mM CaCl2⋅2H2O, 20 mM MgSO4⋅7H2O
-
4.
Plastic Petri dishes.
-
5.
Dissection instruments: sharp Dumont forceps (number 55), brush, glass pipette.
-
6.
Dissection (stereo) microscope.
-
7.
20× PTU solution: 4 mM N-phenylthiourea in 1× E3
-
8.
Fluorescence stereomicroscope.
-
9.
25× tricaine solution: 400 mg tricaine methanesulfonate [MS222], 2.1 mL 1 M Tris pH 9.0, 97.9 mL H2O. Adjust to pH 7.0.
2.1.2 Mounting and Imaging
-
1.
Fertilized zebrafish embryos of specific developmental stages (anesthetized with tricaine solution).
-
2.
Dissection instruments: sharp Dumont forceps (number 55), brush, glass pipette.
-
3.
Dissection (stereo) microscope.
-
4.
Agarose (pegGOLD Universal Agarose; Peqlab).
-
5.
Microwave.
-
6.
Temperature-controlled water bath.
-
7.
Glass-bottom dishes (WillCo Wells BV – GWST-5040).
-
8.
Imaging casting molds for agarose (World Precision Instruments, or self-made using a 3D printer).
-
9.
Confocal microscope, such as LSM880 (Carl Zeiss Microscopy GmbH), including objective lenses (HC Plan-Apochromat 20×/0.8 air, HC Plan-Apochromat 40×/1.2 water, and HC Plan-Apochromat 63×/1.4 oil) and a heating chamber for time-lapse microscopy.
2.2 Manipulations to Study Cell Migration
2.2.1 Microinjections
-
1.
Agarose (pegGOLD Universal Agarose; Peqlab).
-
2.
Zebrafish E3 embryo medium.
-
3.
Plastic Petri dishes.
-
4.
Injection casting mold for agarose (World Precision Instruments).
-
5.
Fertilized zebrafish embryos.
-
6.
Dissection instruments: sharp Dumont forceps (number 55), brush, glass pipette.
-
7.
Glass capillaries (World Precision Instruments).
-
8.
Micropipette puller (Sutter Instrument).
-
9.
Injection mix including (depending on experiment, see Subheading 3.2): 0.05% phenol red (Sigma), plasmid DNA of interest, CAS9 protein (New England Biolabs) or cas9 mRNA (Sigma), guide RNAs (e.g., order via Integrated DNA Technologies), morpholino oligonucleotides (Gene Tools), tol2 mRNA (Sigma).
-
10.
Microloader pipette tips (Eppendorf).
-
11.
Micromanipulation device (World Precision Instruments) attached to compressed air system.
2.2.2 Drug Treatments
-
1.
Materials mentioned in Subheading 2.1.
-
2.
Respective chemicals and solvents; here: IWR-1 (Sigma), dimethyl sulfoxide (DMSO, Sigma).
2.3 Analysis
-
1.
Image processing and analyzing software such as ImageJ/FIJI or Imaris software (Bitplane).
-
2.
Software for data analysis, statistics, and visualization, such as Microsoft Excel, Prism software (GraphPad), or R Statistics software.
3 Methods
3.1 General Vascular Assessment During Embryonal Development
3.1.1 Preparing Embryos for Live Imaging
-
1.
Collect embryos expressing a specific transgene (see Table 1) into an E3-filled plastic petri dish and cultivate at 28.5 °C.
-
2.
Around 6 hpf, sort out dead, amorphous, or unfertilized embryos using a stereomicroscope. Furthermore, determine the exact fertilization time by using the published guide to assess the developmental stage of zebrafish embryos [58].
-
3.
After gastrulation (latest around 24 hpf) supplement the E3 medium with PTU in order to prevent melanocyte formation [59]. This will ensure embryo transparency for vascular assessment via confocal microscopy.
-
4.
Remove the chorion manually under the stereomicroscope by using two sharp Dumont forceps.
-
5.
Anesthetize embryos using tricaine solution, and sort embryos under a fluorescence stereomicroscope for their respective vascular transgene using a brush and Dumont forceps (see Note 1). Positive embryos can be used for further analysis by confocal microscopy.
-
6.
Prepare mounting solution by dissolving 0.3% agarose in E3 medium. Boil briefly in a microwave. After complete dissolution, supplement the agarose with PTU to inhibit pigmentation and with tricaine solution to anesthetize the embryo and prevent movement during microscopy. Cool down and keep agarose flask in a temperature-controlled water bath at 42 °C.
3.1.2 Mounting and Imaging
-
1.
In order to mount embryos for imaging, embed and fix embryos in mounting solution.
-
2.
Embryos can be mounted using two different techniques. Agarose wells can be generated by using an imaging casting mold. To do this, pour mounting solution into an imaging glass-bottom dish and add the respective imaging casting mold. After solidification at room temperature (around 1 h, or: prepare ahead and store at 4 °C, then warm up to room temperature), the cast can be removed and embryos can be transferred into separate agarose wells with a glass pipette (see Note 2). We further recommend fixing the embryos using another drop of mounting solution (see Note 3).
Alternatively, embryos can simply be transferred onto an empty glass-bottom dish and then be fixed with a drop of mounting medium (see Note 3). Depending on your microscope setup, make sure to additionally consider the lens position when mounting your embryos. Both upright and inverted microscopes can be used with this mounting technique (see Note 4).
-
3.
After the agarose has solidified, make sure to place the lid on the glass-bottom dish to avoid excessive evaporation which might compromise specimen integrity during time-lapse imaging (see Note 5).
-
4.
Place the imaging dish in a preheated microscope incubation chamber at 28.5 °C to maintain stable embryo development and to avoid heat-dependent microscope stage drift owing to metal extension upon heating (see Note 6).
-
5.
Select the appropriate magnification for imaging the structure of interest (see Subheadings 3.1.3, 3.1.4 and 3.1.5).
-
6.
Define the x-/y-position and z-stack of your embryos to get an adequate view of the structure of interest. When running a time-lapse series, make sure to consider that cells may migrate out of the field of imaging when defining the image x-/y-position and z-stack depth. It might be necessary to use the tile scan function to observe cells during migration for a longer period, especially at higher magnifications. Make sure to use a suitable time interval for the imaging in order to obtain the desired time resolution of your developmental process (see Note 7).
3.1.3 ISV Imaging
-
1.
Mount the embryo in a lateral position. Image individual embryos from 22 hpf onward to observe initial endothelial cell sprouting and migration.
-
2.
For imaging ISVs, use a 20x magnification lens. For analysis of subcellular structures such as filipodia or intracellular compartments, higher magnification might be necessary. Make sure to use suitable lens immersion substrates according to the lens’ manufacturer’s instructions.
-
3.
For time-lapse analysis, use an interval of 10–20 min to capture cell migration. Subcellular observations might require shorter imaging intervals (see Note 7).
3.1.4 CtA Imaging
-
1.
For imaging the CtAs in the hindbrain of the zebrafish, use two distinct imaging angles. For observations of endothelial sprouting, initial sprout migration, as well as lumen formation, use a lateral point of view. Start imaging from 32 hpf onward to capture the whole CtA angiogenesis.
-
2.
Assess vessel patterning when CtA formation has been finished before starting to image angiogenesis in detail. Use a dorsal imaging view at around 48 hpf. Depending on the microscope setup, the embryos should be placed with the dorsal side pointing toward the lens of the microscope. Include the whole depth range from the skin to the primordial hindbrain channels in your z-stack to include the complete CtA pattern (due to tissue depth, imaging the connections to the BA might prove challenging).
-
3.
Start imaging with a 20× magnification lens. For imaging of filopodia or intracellular compartments, increasing the magnification might be necessary.
-
4.
Use an interval of 10–20 min to capture the migration process when performing time-lapse imaging. Shorter time intervals might be necessary depending on the required resolution (see Note 7).
3.1.5 CCV Imaging
-
1.
To image CCV formation, focus on one side of the zebrafish and study the formation of one CCV from a dorsolateral point of view.
-
2.
Start observing from 32 hpf. This is preferred even though early CCV endothelial cell migration starts from 20 to 22 hpf due to the curved shape of the yolk and the fact that these vessels migrate on top of the yolk syncytial layer (YSL).
-
3.
Slightly turn embryos to a more dorsolateral angle toward the lens, rather than mounting them laterally. The beneficial effect of this mounting technique is a smaller z-stack and a better observation angle to include the entire endothelial cell sheet.
-
4.
Use magnification of 20× to monitor collective cell migration and formation of the vessel. Since the size and shape of CCV endothelial cells allow reasonable observation of intracellular compartments as well as lamellipodia at the leading edge, we frequently use 40× and 63× magnification combined with the tile scan function to study this vessel.
-
5.
When performing time-lapse imaging, use an interval of 10–15 min when examining cellular migration and vessel formation and an interval of 2–5 min when observing lamellipodia at the front and filopodia at the side of the cell sheet (see Note 7).
3.2 Manipulation Techniques to Study Endothelial Cell Migration
3.2.1 Microinjections
A variety of experimental techniques are based on microinjections into the zebrafish embryo which are performed as detailed elsewhere [60]. Below, we provide a protocol for different experiments that can be performed to genetically manipulate zebrafish embryos. Thus, the effect of specific genes and proteins on endothelial cell behavior can be examined in vivo.
-
1.
Prepare injection molds that hold embryos during injection by boiling up 1% agarose in E3 medium using a wedge-shaped injection casting mold and a petri dish. Moreover, prepare your injection needle from glass capillaries by using a micropipette puller.
-
2.
Load your needle with your injection mix using microloader pipette tips, and place the needle into the holder of the micromanipulation device (see Note 8). The injection mix should include a visual control such as phenol red in order to control injection accuracy.
-
3.
Transfer embryos into the injection mold using a glass pipette and adjust orientation with Dumont forceps.
-
4.
Using the micromanipulator, inject either into the embryo’s yolk by passing through the chorion or directly into the cell by entering the cell through the yolk at the back of the embryo (see Note 9). The embryo should be preferably in one-cell stage and maximally in two-cell stage at the time point of injection [58].
-
5.
After injection, transfer the embryos into a dish containing E3 medium and place at 28.5 °C. Hereafter, proceed as described above (Subheading 3.1).
3.2.2 Gain of Function/Vascular Specific Overexpression
To create an overexpression scenario, we inject plasmid DNA according to Subheading 3.2.1 using an endothelial cell-specific promoter fragment of the ETS transcription factor fli1a to drive expression of our gene of interest (here a wild-type or a dominant-negative version of Rab5c, fused to mCherry) [32, 61] (see Note 10). We performed these overexpression studies in endothelial cells to assess the effects on tip versus stalk cell selection during ISV formation (see Subheading 3.3.1). Notably, gene expression via DNA plasmids results in a mosaic gain of function outcome, ideally suited to analyze individual cell behavior (tip versus stalk cell) (see Note 11). To obtain ubiquitous gain of function in the whole embryo, in vitro transcribed mRNA can be injected. The injection mix for the experiment should include the respective plasmid, containing genomic integration sites for transgenesis such as the transposase Tol2. The Tol2 elements consist of inverted DNA repeats that are used for genomic integration in a variety of vertebrate systems such es zebrafish, Xenopus, chicken, mouse, and human [62]. In addition to the plasmid DNA, we include tol2 mRNA, which is transcribed in vivo into the transposase performing genomic integration of the plasmid. Lastly, we include phenol red as a visible marker for injection.
-
1.
Follow steps 1–3 from Subheading 3.2.1.
-
2.
Prepare injection mix for Rab5c-mCherry overexpression: 25 ng/μL plasmid DNA, 1 μL 0.05% phenol red (in water), 250 ng/μL tol2 mRNA. Fill up to 5 μL with water.
-
3.
Inject 2 nL per embryo as in step 4 of Subheading 3.2.1.
-
4.
Follow step 5 of Subheading 3.2.1 and proceed as mentioned in Subheading 3.1.
3.2.3 Loss of Function/Gene Knockdown or Genetic Knockout
Loss of genetic function can be achieved by performing gene knockdown or genetic knockout experiments For gene knockdown, we use either morpholino antisense oligonucleotides to block translation or splicing of a transcript [14] or a CRISPR/Cas9 combination (several guide RNAs targeting the same gene of interest together with Cas9 protein) and inject into zebrafish embryos according to Subheading 3.2.1 [63]. Respective injection mixes are specified below. Nonetheless, genetic knockdown strategies using morpholinos bear the risk of potential off-target effects, and somatic knockdown strategies using CRISPR/Cas9 result in various genetic modifications with no potential prediction regarding the efficiency of the obtained knockout. Therefore, genetic knockouts are often generated [64,65,66]. The most common strategy nowadays is based on CRISPR/Cas9-dependent gene modification [15,16,17,18]. After injections, the embryos need to be grown into adults and then scored for germline transmission into their F1 offspring, and only after growing the F1 into adulthood, heterozygous carrier fish harboring the same mutation are generated. These are then mated to study homozygous gene knockouts in 25% of the F2 offspring embryos. As an example, we analyzed loss of adhesion protein function (ve-cadherin) on collective endothelial cell migration during CCV formation (see Subheading 3.3.3).
-
1.
Follow steps 1–3 from Subheading 3.2.1.
-
2.
For morpholino injection, prepare the following injection mix: X ng/μL morpholino (see Note 12), 1 μL 0.05% phenol red. Fill up to 5 μL with water.
For CRISPR/Cas9 knockdown, prepare this injection mix: 200 pg/nL Cas9 protein (NEB), 500 ng/μL gRNA(s), 1 μL 0.05% phenol red. Fill up to 5 μL with water.
For CRISPR/Cas9 genome editing (knockout), prepare this injection mix: 300 ng/μL cas9 mRNA, 500 ng/μL gRNA, 1 μL 0.05% phenol red. Fill up to 5 μL with water.
-
3.
Inject 2 nL per embryo into the yolk for CRISPR/Cas9 knockdown and 1 nL into the cell for CRISPR/Cas9 genome editing (knockout).
-
4.
Follow step 5 of Subheading 3.2.1 and proceed as mentioned in Subheading 3.1.
3.2.4 Drug Treatments
Besides genetic manipulation experiments, the zebrafish is also a great model for applying drug screenings and pharmacological manipulation of protein function. Most drugs can simply be added to the medium. However, solubility, concentration, and timing will affect the efficacy of the treatment (see Note 13). An exemplary treatment is the block of Wnt signaling using IWR-1, to study its effect on hindbrain vasculature formation (see Subheading 3.3.2).
-
1.
For the treatment transfer dechorionated embryos in E3 medium into 6-well dishes.
-
2.
Replace E3 embryo medium with medium containing freshly DMSO dissolved and in E3 diluted IWR-1 (final concentration of 20 μM) for your incubation period of interest. In our example given below, we incubate the embryos in the inhibitor from 29 to 48 hpf [47].
-
3.
Proceed as mentioned in Subheading 3.1 to assess inhibition phenotype.
3.3 Analysis
3.3.1 Analysis of Tip and Stalk Cell Competition During ISV Formation
ISV formation can be used as a model to study different parameters of angiogenesis in the zebrafish. Live endothelial cell migration can be observed by time-lapse imaging of ISV endothelial cells to study migration parameters such as migration speed, cellular polarity, or filopodia formation. Furthermore, some signaling cascades do not affect overall migration speed, but are required to pass certain checkpoints, so that deficiencies result in stalling of ISV development, which is most often observed at the level of the horizontal myoseptum [67,68,69]. Other important parameters can be endothelial cell fate specifications, including arterial/venous vessel fates or tip/stalk cell identity [7, 46, 70]. In this example, we show how to analyze the role of the early endosomal Rab GTPase Rab5C on tip/stalk cell formation [46], using a plasmid driving endothelial cell-specific expression of an mCherry-Rab5C fusion protein via the fli1a promoter, which was injected into Tg(kdrl:GFP)s843 embryos [11]. Expression of wild-type mCherry-Rab5C was compared to expression of a dominant-negative mCherry-Rab5C mutant and mCherry only (Fig. 3a). As these injections result in mosaic overexpression of mCherry or mCherry-tagged Rab5C in endothelial cells, the mCherry-positive cells are scored for their position within the developing ISV (tip or stalk) in order to assess the effect of Rab5C on tip/stalk cell specification within the developing vessel (Fig. 3b, c).
-
1.
Take confocal z-stacks of the ISVs of mCherry-positive embryos around 32 hpf (see Subheadings 3.1.2 and 3.1.3) (see Fig. 3c).
-
2.
Open the images with image processing and analyzing software such as ImageJ/FIJI or Imaris to analyze the images. For this analysis, each embryo is observed individually for mCherry-positive cell localizations. Hence, all mCherry-positive endothelial cells must be counted and their localization noted (tip or stalk of the sprout).
-
3.
For each embryo, calculate the percentage values of the cellular localization to determine the relative numbers for each localization, e.g.:
-
total mCherry-positive cell number = 5 cells [100%];
-
mCherry-positive cells in the stalk of the sprout = 1 [20%];
-
mCherry-positive cells at the tip of the sprout = 4 [80%].
-
-
4.
Plot percentage values in a graph to visualize mCherry-positive cell contributions (Fig. 3b).
3.3.2 Analysis of Sprouting Angiogenesis During CtA Formation
The intracerebral CtAs of the zebrafish are another well-known model to study brain angiogenesis. CtA cells invade the hindbrain parenchyma around 32 hpf to form blood vessels around 48 hpf [48,49,50]. Comparative analyses regarding endothelial cell migration parameters and vessel formation can be assessed in this vascular bed. In this example, we show how to analyze CtA number, endothelial cell connection to the BA, and interconnections between endothelial sprouts in control conditions and in embryos treated with the Wnt-signaling inhibitor IWR-1 (Fig. 4a; see Subheading 3.2.4) [47]. The zebrafish line used in this example expresses actin-fused GFP in endothelial cells to visualize the cytoskeleton and filopodia (Tg(kdrl:Lifeact-GFP)mu240).
-
1.
Take dorsal z-stacks of the CtAs around 48 hpf (see Subheadings 3.1.2 and 3.1.4) (see Fig. 4b).
-
2.
Open the images with image processing and analyzing software such as ImageJ/FIJI or Imaris to analyze the images. Here, we started the analysis by counting individual CtA sprouts in separate embryos in order to assess vessel patterning.
-
3.
Count the number of sprouts that established a connection to the BA to form a completed and lumenized vessel. Calculate the percentage value of these connections for every embryo, e.g., ten sprouts [100%], of which seven are connected to the BA [70%].
-
4.
In order to further assess hindbrain vascular patterning, examine the number of (ectopic) interconnections between individual CtA sprouts. Count the number of interconnections and calculate the percentage value of the total number of sprouts, e.g., ten sprouts [100%], of which five form interconnections [50%].
-
5.
Plot the values in individual graphs to visualize the effect of Wnt-signaling inhibition on CtA formation (Fig. 4c).
3.3.3 Analysis of Collective Endothelial Cell Migration Behavior During CCV Formation
During CCV formation, endothelial cells migrate collectively as a cell sheet which clearly differs from the single tip cell-like sprouting of other blood vessels [6, 24, 51]. In order to assess vascular development in this vascular bed, we quantify the angiogenic parameters that can be measured at individual time points to quantify angiogenic progress. Additionally, performing time-lapse imaging during CCV development allows a vivid evaluation of migration parameters such as endothelial cell migration capacity and directionality. In this example, we analyzed CCV formation in two different genetic backgrounds, wild-type and ve-cadherin mutant zebrafish embryos. VE-cadherin is an important adherens junction molecule which is exclusively expressed in endothelial cells to allow cell-cell adhesion, but it is also involved in regulating directional collective cell migration [51, 71, 72]. For this analysis, we used embryos that express a vascular-specific transgene encoding a nuclear localization signal (nls) fused to GFP and a transgene to visualize actin structures to monitor cellular shape (Tg(kdrl:nls-EGFP)zf109; (kdrl:Lifeact-GFP)mu240).
-
1.
Perform time-lapse imaging of the developing CCV in wild-type and VE-cadherin-deficient embryos from 32 to 38 hpf (see Subheadings 3.1.2 and 3.1.5) (see Fig. 5a).
-
2.
Transfer the time-lapse movies into image processing and analyzing software capable of handling files of bigger size, such as Imaris. Consider that these movies might contain several z-stacks of different embryos with several time points and may therefore amount to a file size of several gigabytes.
-
3.
To obtain values for migration track length, speed, and directionality (straightness of the tracks), track individual CCV endothelial cells throughout the complete time-lapse movie. You can either use an automated signal threshold-based identification of cells by targeting the nucleus of a cell, or manually select the nucleus of an individual cell throughout the complete time-lapse series using a Spots tool (e.g., the manual Spot Track function in Imaris) (see Note 14).
-
4.
After selecting all cell tracks, export the track length, migration speed, and track displacement (see Note 15). Migration directionality is calculated as the ratio of the track displacement and total track length.
-
5.
Plot the values for both conditions together in graphs to visualize migration track length and migration speed to assess migration capacity and the directionality to evaluate migration efficiency (Fig. 5b).
4 Notes
-
1.
Using a higher concentration of tricaine (more than 1 mL in 25 mL E3; i.e., more than the recommended 150 mg/L [73]) will stop the heartbeat of the embryo which might have additional effects on your analysis.
-
2.
You can simply use the embryo medium that includes PTU and tricaine to transfer the embryos using a glass pipette. Carefully transfer the embryos to not harm them (we recommend a glass pipette with a rounded tip) and to not destroy the agarose well with the tip of the pipette. Remove well-overflowing liquid to ensure fixed embryo positioning in the wells.
-
3.
Before adding the agarose, make sure the embryo position is roughly suitable (e.g., anterior-posterior orientation and lateral/dorsal point of view). Carefully arrange the embryos using a brush or Dumont forceps. Be aware that poking the yolk sac or embryo tissue might harm or kill the embryo. Upon agarose addition, use Dumont forceps to maintain adequate embryo position until agarose solidification.
When performing time-lapse imaging of developmental stages between 20 and 28 hpf, it is important to consider the growth-dependent embryo changes in body curvature, e.g., straightening of the tail region, so that the desired region can be stably imaged. Therefore, agarose at the embryo tail should be removed to allow embryo bending and growing. After imaging, embryos can be removed from the agarose by using forceps, e.g., to extract DNA and analyze the genotype via polymerase chain reaction techniques.
-
4.
It might be necessary to adjust the thickness of the agarose layer on your glass-bottom dish when using the agarose well technique. For inverted microscopes, we recommend a thin layer of agarose in order to ensure that the specimen will stay in optimal focus distance, especially when using higher magnification lenses, which require short focus distance.
-
5.
To avoid evaporation, you can also add more mounting solution or E3 embryo medium that includes PTU and tricaine to increase the volume of medium in the imaging dish. However, if you only mount the embryos in single agarose drops, too much liquid medium (that does not contain any agarose) might lead to detachment of the agarose drops including your specimen. In this case, we recommend using agarose-containing mounting solution.
-
6.
This might be critical for time-lapse imaging since minor stage drift can lead to noticeable shifts in the z-position of the embryo. You can counteract this drift by additionally using a time-lapse-based autofocus/definite focus function on your confocal microscope.
-
7.
Since we use z-stacks to obtain 3D images, scanning time of several embryos might require prolonged imaging time. In this case, total z-stack size, number of z-scans, and the range between two scans in z-direction can be adjusted to decrease scanning time. Furthermore, pixel dwell time can be reduced to allow short imaging time. Although these changes allow to sustain the range of the time-lapse, they may reduce image quality.
-
8.
Make sure to work RNAse free when preparing an injection mix containing RNA and when loading it into the needle.
-
9.
Depending on the experimental design, you should consider direct injection into the cell. Injecting transgenesis components directly into the cell leads to an earlier integration of the plasmid into the embryo’s DNA. This might lead to a higher number of cells expressing the transgene in the embryo at the time of analysis and to a higher probability of germline integration.
-
10.
It is also very common to use the vascular endothelial growth factor receptor 2 (vegfr2/kdrl) promoter when a gene of interest should be expressed in endothelial cells [32, 61].
-
11.
Alternatively, cell transplantation studies can be used to further examine whether your gene of interest acts in a cell-autonomous way to control processes such as tip cell fate decision. For instance, cells from a mutant donor embryo can be transplanted into a wild-type host embryo in order to study the cellular fate of wild-type and gene knockout endothelial cells during tip and stalk cell selection or to investigate the significance of a specific signaling pathway during ISV formation [74,75,76].
-
12.
The working concentration that is needed actually depends on the morpholino. It is recommended to start with a concentration of 1 ng/nL to start with 2 ng of morpholino. Increase the doses to assess for the desired phenotype and for potential toxicity. We recommend to be cautious when using more than 5 ng of morpholino since this has been shown to cause potential side effects such as p53 upregulation [64, 65].
-
13.
In general, dechorionation prior to the treatment is necessary since the chorion provides a natural barrier to protect the embryos. Furthermore, depending on the inhibitor, different solvents have to be used. Pay attention to the maximum concentration as well as the exposure time of these solvents that should be used on zebrafish embryos without disturbing their development. For example, a DMSO concentration of more than 0.1% should not be exceeded, as that disturbs heart development. Moreover, when embryos are mounted for imaging in agarose, make sure to include the drug in the agarose mixture to maintain pharmacological efficiency during imaging.
-
14.
In the case of cell divisions, tracks can be split up into two new separate tracks that originate from one track to follow the complete migration track of the original cell.
-
15.
The migration speed can also be calculated as the track length divided by the time passing while tracking. The displacement describes the distance between the first and last position of the cell and can be used to obtain the directionality value for the migration.
References
Risau W, Flamme I (1995) Vasculogenesis. Annu Rev Cell Dev Biol 11:73–91. https://doi.org/10.1146/annurev.cb.11.110195.000445
Risau W (1997) Mechanisms of angiogenesis. Nature 386(6626):671–674. https://doi.org/10.1038/386671a0
Adams RH, Eichmann A (2010) Axon guidance molecules in vascular patterning. Cold Spring Harb Perspect Biol 2(5):a001875. https://doi.org/10.1101/cshperspect.a001875
Gerhardt H (2008) VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 4(4):241–246. https://doi.org/10.4161/org.4.4.7414
Herbert SP, Stainier DY (2011) Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 12(9):551–564. https://doi.org/10.1038/nrm3176
Schuermann A, Helker CS, Herzog W (2014) Angiogenesis in zebrafish. Semin Cell Dev Biol 31:106–114. https://doi.org/10.1016/j.semcdb.2014.04.037
Eberlein J, Herdt L, Malchow J, Rittershaus A, Baumeister S, Helker CS (2021) Molecular and cellular mechanisms of vascular development in zebrafish. Life (Basel) 11(10). https://doi.org/10.3390/life11101088
Galanternik MSAN, Weinstein BM (2020) The zebrafish cardiovascular system. In: Cartner SE, Eisen JS, Farmer SC, Guillemin KJ, Kent ML, Sanders GE (eds) The zebrafish in biomdecial research. Biology, Husbandry, Diseases and Research
Gore AV, Monzo K, Cha YR, Pan W, Weinstein BM (2012) Vascular development in the zebrafish. Cold Spring Harb Perspect Med 2(5):a006684. https://doi.org/10.1101/cshperspect.a006684
Beis D, Stainier DY (2006) In vivo cell biology: following the zebrafish trend. Trends Cell Biol 16(2):105–112. https://doi.org/10.1016/j.tcb.2005.12.001
Lawson ND, Weinstein BM (2002) In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248(2):307–318. https://doi.org/10.1006/dbio.2002.0711
Thisse C, Zon LI (2002) Organogenesis – heart and blood formation from the zebrafish point of view. Science 295(5554):457–462. https://doi.org/10.1126/science.1063654
Quaife NM, Watson O, Chico TJ (2012) Zebrafish: an emerging model of vascular development and remodelling. Curr Opin Pharmacol 12(5):608–614. https://doi.org/10.1016/j.coph.2012.06.009
Nasevicius A, Ekker SC (2000) Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet 26(2):216–220. https://doi.org/10.1038/79951
Jao LE, Wente SR, Chen W (2013) Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc Natl Acad Sci U S A 110(34):13904–13909. https://doi.org/10.1073/pnas.1308335110
Auer TO, Del Bene F (2014) CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish. Methods 69(2):142–150. https://doi.org/10.1016/j.ymeth.2014.03.027
Chang N, Sun C, Gao L, Zhu D, Xu X, Zhu X, Xiong JW, Xi JJ (2013) Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res 23(4):465–472. https://doi.org/10.1038/cr.2013.45
Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK (2013) Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31(3):227–229. https://doi.org/10.1038/nbt.2501
Finckbeiner S, Ko PJ, Carrington B, Sood R, Gross K, Dolnick B, Sufrin J, Liu P (2011) Transient knockdown and overexpression reveal a developmental role for the zebrafish enosf1b gene. Cell Biosci 1:32. https://doi.org/10.1186/2045-3701-1-32
Sassen WKR (2015) A molecular toolbox for genetic manipulation of zebrafish. Adv Genom Genet 2015(5):151–163
Weber M, Huisken J (2011) Light sheet microscopy for real-time developmental biology. Curr Opin Genet Dev 21(5):566–572. https://doi.org/10.1016/j.gde.2011.09.009
Weber M, Mickoleit M, Huisken J (2014) Multilayer mounting for long-term light sheet microscopy of zebrafish. J Vis Exp 84:e51119. https://doi.org/10.3791/51119
Baldessari D, Mione M (2008) How to create the vascular tree? (latest) help from the zebrafish. Pharmacol Ther 118(2):206–230. https://doi.org/10.1016/j.pharmthera.2008.02.010
Ellertsdottir E, Lenard A, Blum Y, Krudewig A, Herwig L, Affolter M, Belting HG (2010) Vascular morphogenesis in the zebrafish embryo. Dev Biol 341(1):56–65. https://doi.org/10.1016/j.ydbio.2009.10.035
Hamm MJ, Kirchmaier BC, Herzog W (2016) Sema3d controls collective endothelial cell migration by distinct mechanisms via Nrp1 and PlxnD1. J Cell Biol 215(3):415–430. https://doi.org/10.1083/jcb.201603100
Stainier DY, Fouquet B, Chen JN, Warren KS, Weinstein BM, Meiler SE, Mohideen MA, Neuhauss SC, Solnica-Krezel L, Schier AF, Zwartkruis F, Stemple DL, Malicki J, Driever W, Fishman MC (1996) Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development 123:285–292
Kikuchi K, Holdway JE, Werdich AA, Anderson RM, Fang Y, Egnaczyk GF, Evans T, Macrae CA, Stainier DY, Poss KD (2010) Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature 464(7288):601–605. https://doi.org/10.1038/nature08804
Jopling C, Sleep E, Raya M, Marti M, Raya A, Izpisua Belmonte JC (2010) Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464(7288):606–609. https://doi.org/10.1038/nature08899
Xu C, Hasan SS, Schmidt I, Rocha SF, Pitulescu ME, Bussmann J, Meyen D, Raz E, Adams RH, Siekmann AF (2014) Arteries are formed by vein-derived endothelial tip cells. Nat Commun 5:5758. https://doi.org/10.1038/ncomms6758
Isogai S, Horiguchi M, Weinstein BM (2001) The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev Biol 230(2):278–301. https://doi.org/10.1006/dbio.2000.9995
Hogan BM, Herpers R, Witte M, Helotera H, Alitalo K, Duckers HJ, Schulte-Merker S (2009) Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries. Development 136(23):4001–4009. https://doi.org/10.1242/dev.039990
Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY (2005) Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132(23):5199–5209. https://doi.org/10.1242/dev.02087
Vanhollebeke B, Stone OA, Bostaille N, Cho C, Zhou Y, Maquet E, Gauquier A, Cabochette P, Fukuhara S, Mochizuki N, Nathans J, Stainier DY (2015) Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent Wnt/beta-catenin pathway during brain angiogenesis. elife 4. https://doi.org/10.7554/eLife.06489
Henry KM, Loynes CA, Whyte MK, Renshaw SA (2013) Zebrafish as a model for the study of neutrophil biology. J Leukoc Biol 94(4):633–642. https://doi.org/10.1189/jlb.1112594
Bussmann J, Schulte-Merker S (2011) Rapid BAC selection for tol2-mediated transgenesis in zebrafish. Development 138(19):4327–4332. https://doi.org/10.1242/dev.068080
Proulx K, Lu A, Sumanas S (2010) Cranial vasculature in zebrafish forms by angioblast cluster-derived angiogenesis. Dev Biol 348(1):34–46. https://doi.org/10.1016/j.ydbio.2010.08.036
Motoike T, Loughna S, Perens E, Roman BL, Liao W, Chau TC, Richardson CD, Kawate T, Kuno J, Weinstein BM, Stainier DY, Sato TN (2000) Universal GFP reporter for the study of vascular development. Genesis 28(2):75–81. https://doi.org/10.1002/1526-968x(200010)28:2<75::aid-gene50>3.0.co;2-s
Traver D, Paw BH, Poss KD, Penberthy WT, Lin S, Zon LI (2003) Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol 4(12):1238–1246. https://doi.org/10.1038/ni1007
Hogan BM, Bos FL, Bussmann J, Witte M, Chi NC, Duckers HJ, Schulte-Merker S (2009) Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 41(4):396–398. https://doi.org/10.1038/ng.321
Sacilotto N, Monteiro R, Fritzsche M, Becker PW, Sanchez-Del-Campo L, Liu K, Pinheiro P, Ratnayaka I, Davies B, Goding CR, Patient R, Bou-Gharios G, De Val S (2013) Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development. Proc Natl Acad Sci U S A 110(29):11893–11898. https://doi.org/10.1073/pnas.1300805110
Okuda KS, Astin JW, Misa JP, Flores MV, Crosier KE, Crosier PS (2012) lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish. Development 139(13):2381–2391. https://doi.org/10.1242/dev.077701
Umans RA, Henson HE, Mu F, Parupalli C, Ju B, Peters JL, Lanham KA, Plavicki JS, Taylor MR (2017) CNS angiogenesis and barriergenesis occur simultaneously. Dev Biol 425(2):101–108. https://doi.org/10.1016/j.ydbio.2017.03.017
Kwon HB, Wang S, Helker CS, Rasouli SJ, Maischein HM, Offermanns S, Herzog W, Stainier DY (2016) In vivo modulation of endothelial polarization by Apelin receptor signalling. Nat Commun 7:11805. https://doi.org/10.1038/ncomms11805
Zygmunt T, Gay CM, Blondelle J, Singh MK, Flaherty KM, Means PC, Herwig L, Krudewig A, Belting HG, Affolter M, Epstein JA, Torres-Vazquez J (2011) Semaphorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy receptor sFlt1. Dev Cell 21(2):301–314. https://doi.org/10.1016/j.devcel.2011.06.033
Chi NC, Shaw RM, De Val S, Kang G, Jan LY, Black BL, Stainier DY (2008) Foxn4 directly regulates tbx2b expression and atrioventricular canal formation. Genes Dev 22(6):734–739. https://doi.org/10.1101/gad.1629408
Kempers L, Wakayama Y, van der Bijl I, Furumaya C, De Cuyper IM, Jongejan A, Kat M, van Stalborch AD, van Boxtel AL, Hubert M, Geerts D, van Buul JD, de Korte D, Herzog W, Margadant C (2021) The endosomal RIN2/Rab5C machinery prevents VEGFR2 degradation to control gene expression and tip cell identity during angiogenesis. Angiogenesis 24(3):695–714. https://doi.org/10.1007/s10456-021-09788-4
Hubner K, Cabochette P, Dieguez-Hurtado R, Wiesner C, Wakayama Y, Grassme KS, Hubert M, Guenther S, Belting HG, Affolter M, Adams RH, Vanhollebeke B, Herzog W (2018) Wnt/beta-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling. Nat Commun 9(1):4860. https://doi.org/10.1038/s41467-018-07302-x
Ulrich F, Ma LH, Baker RG, Torres-Vazquez J (2011) Neurovascular development in the embryonic zebrafish hindbrain. Dev Biol 357(1):134–151. https://doi.org/10.1016/j.ydbio.2011.06.037
Fujita M, Cha YR, Pham VN, Sakurai A, Roman BL, Gutkind JS, Weinstein BM (2011) Assembly and patterning of the vascular network of the vertebrate hindbrain. Development 138(9):1705–1715. https://doi.org/10.1242/dev.058776
Bussmann J, Wolfe SA, Siekmann AF (2011) Arterial-venous network formation during brain vascularization involves hemodynamic regulation of chemokine signaling. Development 138(9):1717–1726. https://doi.org/10.1242/dev.059881
Helker CS, Schuermann A, Karpanen T, Zeuschner D, Belting HG, Affolter M, Schulte-Merker S, Herzog W (2013) The zebrafish common cardinal veins develop by a novel mechanism: lumen ensheathment. Development 140(13):2776–2786. https://doi.org/10.1242/dev.091876
Thisse B, Thisse C (2014) In situ hybridization on whole-mount zebrafish embryos and young larvae. Methods Mol Biol 1211:53–67. https://doi.org/10.1007/978-1-4939-1459-3_5
Sauteur L, Krudewig A, Herwig L, Ehrenfeuchter N, Lenard A, Affolter M, Belting HG (2014) Cdh5/VE-cadherin promotes endothelial cell interface elongation via cortical actin polymerization during angiogenic sprouting. Cell Rep 9(2):504–513. https://doi.org/10.1016/j.celrep.2014.09.024
Cai D, Chen SC, Prasad M, He L, Wang X, Choesmel-Cadamuro V, Sawyer JK, Danuser G, Montell DJ (2014) Mechanical feedback through E-cadherin promotes direction sensing during collective cell migration. Cell 157(5):1146–1159. https://doi.org/10.1016/j.cell.2014.03.045
Grashoff C, Hoffman BD, Brenner MD, Zhou R, Parsons M, Yang MT, McLean MA, Sligar SG, Chen CS, Ha T, Schwartz MA (2010) Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics. Nature 466(7303):263–266. https://doi.org/10.1038/nature09198
Kumar A, Ouyang M, Van den Dries K, McGhee EJ, Tanaka K, Anderson MD, Groisman A, Goult BT, Anderson KI, Schwartz MA (2016) Talin tension sensor reveals novel features of focal adhesion force transmission and mechanosensitivity. J Cell Biol 213(3):371–383. https://doi.org/10.1083/jcb.201510012
Lagendijk AK, Gomez GA, Baek S, Hesselson D, Hughes WE, Paterson S, Conway DE, Belting HG, Affolter M, Smith KA, Schwartz MA, Yap AS, Hogan BM (2017) Live imaging molecular changes in junctional tension upon VE-cadherin in zebrafish. Nat Commun 8(1):1402. https://doi.org/10.1038/s41467-017-01325-6
Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203(3):253–310. https://doi.org/10.1002/aja.1002030302
Elsalini OA, Rohr KB (2003) Phenylthiourea disrupts thyroid function in developing zebrafish. Dev Genes Evol 212(12):593–598. https://doi.org/10.1007/s00427-002-0279-3
Westerfield M (1993) The zebrafish book; a guide for the laboratory use of zebrafish (Brachydanio rerio), vol Eugene, 2nd edn. University of Oregon Press
Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4–10. https://doi.org/10.1159/000088478
Kawakami K (2007) Tol2: a versatile gene transfer vector in vertebrates. Genome Biol 8(Suppl 1):S7. https://doi.org/10.1186/gb-2007-8-s1-s7
Wu RS, Lam II, Clay H, Duong DN, Deo RC, Coughlin SR (2018) A rapid method for directed gene knockout for screening in G0 zebrafish. Dev Cell 46(1):112–125. e114. https://doi.org/10.1016/j.devcel.2018.06.003
Stainier DYR, Raz E, Lawson ND, Ekker SC, Burdine RD, Eisen JS, Ingham PW, Schulte-Merker S, Yelon D, Weinstein BM, Mullins MC, Wilson SW, Ramakrishnan L, Amacher SL, Neuhauss SCF, Meng A, Mochizuki N, Panula P, Moens CB (2017) Guidelines for morpholino use in zebrafish. PLoS Genet 13(10):e1007000. https://doi.org/10.1371/journal.pgen.1007000
Schulte-Merker S, Stainier DY (2014) Out with the old, in with the new: reassessing morpholino knockdowns in light of genome editing technology. Development 141(16):3103–3104. https://doi.org/10.1242/dev.112003
Kok FO, Shin M, Ni CW, Gupta A, Grosse AS, van Impel A, Kirchmaier BC, Peterson-Maduro J, Kourkoulis G, Male I, DeSantis DF, Sheppard-Tindell S, Ebarasi L, Betsholtz C, Schulte-Merker S, Wolfe SA, Lawson ND (2015) Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. Dev Cell 32(1):97–108. https://doi.org/10.1016/j.devcel.2014.11.018
Wang CH, Chen IH, Kuo MW, Su PT, Lai ZY, Wang CH, Huang WC, Hoffman J, Kuo CJ, You MS, Chuang YJ (2011) Zebrafish Thsd7a is a neural protein required for angiogenic patterning during development. Dev Dyn 240(6):1412–1421. https://doi.org/10.1002/dvdy.22641
Yukiura H, Hama K, Nakanaga K, Tanaka M, Asaoka Y, Okudaira S, Arima N, Inoue A, Hashimoto T, Arai H, Kawahara A, Nishina H, Aoki J (2011) Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish. J Biol Chem 286(51):43972–43983. https://doi.org/10.1074/jbc.M111.301093
Helker CS, Eberlein J, Wilhelm K, Sugino T, Malchow J, Schuermann A, Baumeister S, Kwon HB, Maischein HM, Potente M, Herzog W, Stainier DY (2020) Apelin signaling drives vascular endothelial cells toward a pro-angiogenic state. elife 9. https://doi.org/10.7554/eLife.55589
Geudens I, Coxam B, Alt S, Gebala V, Vion AC, Meier K, Rosa A, Gerhardt H (2019) Artery-vein specification in the zebrafish trunk is pre-patterned by heterogeneous Notch activity and balanced by flow-mediated fine-tuning. Development 146(16). https://doi.org/10.1242/dev.181024
Dejana E, Orsenigo F, Lampugnani MG (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121(Pt 13):2115–2122. https://doi.org/10.1242/jcs.017897
Carvalho JR, Fortunato IC, Fonseca CG, Pezzarossa A, Barbacena P, Dominguez-Cejudo MA, Vasconcelos FF, Santos NC, Carvalho FA, Franco CA (2019) Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration. elife 8. https://doi.org/10.7554/eLife.45853
Collymore C, Tolwani A, Lieggi C, Rasmussen S (2014) Efficacy and safety of 5 anesthetics in adult zebrafish (Danio rerio). J Am Assoc Lab Anim Sci 53(2):198–203
Siekmann AF, Lawson ND (2007) Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445(7129):781–784. https://doi.org/10.1038/nature05577
Hasan SS, Tsaryk R, Lange M, Wisniewski L, Moore JC, Lawson ND, Wojciechowska K, Schnittler H, Siekmann AF (2017) Endothelial Notch signalling limits angiogenesis via control of artery formation. Nat Cell Biol 19(8):928–940. https://doi.org/10.1038/ncb3574
Yu PC, Gu SY, Bu JW, Du JL (2010) TRPC1 is essential for in vivo angiogenesis in zebrafish. Circ Res 106(7):1221–1232. https://doi.org/10.1161/CIRCRESAHA.109.207670
Acknowledgments
We thank Marcus Freise and Dr. Yuki Wakayama for providing experimental images used in this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Copyright information
© 2023 The Authors
About this protocol
Cite this protocol
Hubert, M., Herzog, W. (2023). Analysis of Vascular Morphogenesis in Zebrafish. In: Margadant, C. (eds) Cell Migration in Three Dimensions. Methods in Molecular Biology, vol 2608. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2887-4_24
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2887-4_24
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2886-7
Online ISBN: 978-1-0716-2887-4
eBook Packages: Springer Protocols